ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
aTYR PHARMA INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.17−0.00 (-1.32%)
Close on Oct 19, 2026
- Market cap
- $16.84M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of aTYR PHARMA's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 16, 2026 | Oct 16, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2026 | Sep 24, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 16, 2026 | Sep 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 7, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2026 | Aug 7, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2026 | Jun 8, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 1, 2026 | Jun 1, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 26, 2026 | Mar 26, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 5, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2026 | Mar 5, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 4, 2025 | Dec 5, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2025 | Sep 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 7, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 7, 2025 | May 7, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 19, 2025 | Mar 19, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2025 | Mar 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2024 | Dec 23, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2024 | Dec 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 7, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2024 | Nov 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 22, 2024 | Jul 22, 2024 | SEC EDGAR |
| Current report | 8-K | May 22, 2024 | May 29, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 2, 2024 | SEC EDGAR |
| Current report | 8-K | May 2, 2024 | May 2, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | May 22, 2024 | Apr 5, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Mar 14, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 14, 2024 | Mar 14, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 9, 2023 | SEC EDGAR |